The program also includes a Resident Symposium and Workshop and a plenary session dealing with the latest government issues and what is being done to protect your specialty. This year's Dr. Luther Brady Lecture will be presented by Bahman Emami, M.D., of Loyola University. There's something for everyone in a relaxed and friendly environment, a welcome departure from most radiation oncology meetings! Make sure to visit ACRO.org as more information becomes available!READ MORE

ResearchSEA via Medical XpressScientists at the Bioinformatics Institute and Genome Institute of Singapore, research institutes under the Agency for Science, Technology and Research, have made discoveries that could lead to new ways of diagnosing and treating breast cancer. The scientists from both institutes used large-scale genomic data of breast cancers, demonstrating the use of computational techniques to increase understanding of diseases and improve patient treatments.READ MORE

Cancer Therapy Advisor Patient-reported bowel symptoms were similar between patients with intermediate-risk localized prostate cancer who received hypofractionated radiotherapy compared with patients who received a standard fractionation schedule, according to a study published online ahead of print in The Lancet Oncology.READ MORE

The Scripps Research Institute via News-Medical.netCancer metastasis occurs when tumor cells escape from a primary tumor, via the blood stream, and establish tumors in secondary locations. When the metastases are found in distant tissues and organs, doctors call this stage IV cancer, and the survival rate is low.
Now scientists at The Scripps Research Institute have been awarded a grant of more than $1.8 million from the National Institutes of Health's National Cancer Institute to investigate the molecular machinery involved in metastasis. This basic research could one day point to new approaches to help patients.READ MORE

.

PRODUCT SHOWCASE

Gold Anchor - A great fiducial markerMinimally invasive with industry leading thin 25G and 22G needles. Anchors directly, enabling CT same day as implantation. Great visibility, also on MRI.

MedPage TodayDelivery of higher doses of radiotherapy improves local control and overall survival in inoperable intrahepatic cholangiocarcinoma, a retrospective dose analysis study has demonstrated.
A biologic equivalent dose greater than 80.5 Gy seems to be an ablative dose of RT for large IHCCs, with long-term survival rates that compare favorably with resection, according to Christopher H. Crane, MD, at the University of Texas MD Anderson Cancer Center in Houston, and colleagues.READ MORE

University of Salford via Medical XpressA study in the Proceedings of the National Academy of Sciences shows that some forms of the single-celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells. Research from an international collaboration has identified possible new approaches to curing parasitic diseases such as sleeping sickness and toxoplasmosis.READ MORE

University of California, Los Angeles Health Sciences via News-Medical.netNow, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer - from the time a patient checks in for his first appointment to his post-treatment follow-up testing - using time-driven activity-based costing. And they found a wide variation in costs for the various available treatments that remained consistent over a 12-year period, indicating a better method to monitor costs could save valuable healthcare dollars, said study first author Dr. Aaron Laviana, a fifth year urology resident.READ MORE

Medical News TodayWhen cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don't have the weapons to kill the cancer.
"If we have a way to manipulate the metabolic pathway, the T cells may be healthier," says senior author Weiping Zou, M.D., Ph.D., Charles B. de Nancrede Professor of Surgery, Immunology and Biology at the University of Michigan Medical School. The finding, published in Nature Immunology, suggests a potential metabolic pathway against cancer.READ MORE

Disclaimer: Stories and advertisements from sources other than ACRO do not reflect ACRO's positions or policies and there is no implied endorsement by ACRO of any products or services. Content from sources other than that identified as being from ACRO appears in the RadOnc Weekly to enhance readers' understanding of how media coverage shapes perceptions of Radiation Oncology, and to educate readers about what their patients and other healthcare professionals are seeing in the popular press.

American College of Radiation Oncology 5272 River Road | Bethesda, MD 20816 | 301-718-6515 |Contact Us

Learn how to add us to your safe sender list so our emails get to your inbox.